Data / Drug companies / Octinoxate, titanium dioxide, zinc oxide
Octinoxate, titanium dioxide, zinc oxide: 7 companies and 59 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Octinoxate, titanium dioxide, zinc oxide is listed in the FDA National Drug Code Directory by 7 companies, with 59 products in commercial distribution. 0 of the products (0.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are cream; powder; emulsion, and the newest product started marketing on August 3, 2026.
The request: Get every company that lists octinoxate, titanium dioxide, zinc oxide in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 7
- Products
- 59
- Generic (ANDA) products
- 0 (0.0%)
- Application numbers
- 1
- Routes
- Topical
- Brand names
- Perfect Glow BB Cream Sunscreen SPF 30 - Fair, Perfect Glow BB Cream Sunscreen SPF 30 - Medium Tan, Perfect Glow BB Cream Sunscreen SPF 30 - Tan, Perfect Glow BB Cream Sunscreen SPF 30 - Deep, Esika Colorfix Polvos 32H Polvo Compacto Facial de Alta Cobertura FPS 15 180-F, Capture Dreamskin Fresh and Perfect Cushion With Sunscreen Broad Spectrum SPF 50 030, Capture Dreamskin Fresh and Perfect Cushion With Sunscreen Broad Spectrum SPF 50 000, Light Illusion Luminous Makeup Nude-Skin Feel SPF18 Mocha
- openFDA record search
- api.fda.gov
Companies that list octinoxate, titanium dioxide, zinc oxide
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Pur-lisse Beauty, LLC | 22 | cream | Over the counter monograph drugs | December 28, 2022 |
| Cosmax USA, Corporation | 15 | cream | Over the counter monograph drugs | February 15, 2018 |
| Bel Star S a | 12 | powder | Over the counter monograph drugs | August 3, 2026 |
| Laboratoires M&L | 4 | cream | Over the counter monograph drugs | December 16, 2016 |
| Parfums Christian Dior | 4 | emulsion | Over the counter monograph drugs | July 1, 2018 |
| Boscia LLC | 1 | cream | Over the counter monograph drugs | November 7, 2012 |
| Solazyme, Inc. | 1 | cream | Over the counter monograph drugs | August 1, 2012 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Cream | 43 | 72.9% |
| Powder | 12 | 20.3% |
| Emulsion | 4 | 6.8% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 59 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Copper Absorption Inhibitor | 4 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.